Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents

IMPORTANCE: In the US, hepatocellular carcinoma (HCC), primarily associated with hepatitis C virus (HCV) infection, is the fastest rising cause of cancer-related death. Wider use of highly effective direct-acting antiviral agents (DAAs) substantially reduces the burden of chronic HCV infection, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiushi, Ayer, Turgay, Adee, Madeline G., Wang, Xiaojie, Kanwal, Fasiha, Chhatwal, Jagpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675109/
https://www.ncbi.nlm.nih.gov/pubmed/33206188
http://dx.doi.org/10.1001/jamanetworkopen.2020.21173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675109/
https://www.ncbi.nlm.nih.gov/pubmed/33206188
http://dx.doi.org/10.1001/jamanetworkopen.2020.21173

Ejemplares similares